Evidence map›Paper›PMID 33667592›Full record

ArticleNeuroscience2021

Delayed Exercise-induced Upregulation of Angiogenic Proteins and Recovery of Motor Function after Photothrombotic Stroke in Mice.

Abdullah Al Shoyaib, Faisal F Alamri, Abbie Biggers, Serob T Karamyan, Thiruma V Arumugam, Fakhrul Ahsan, Constantinos M Mikelis, Taslim A Al-Hilal, Vardan T Karamyan

Open access · greenAbstract read
In one paragraph

Article in Neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Abdullah Al ShoyaibDepartment of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, Amarillo, USA.
Faisal F AlamriDepartment of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, Amarillo, USA.
Abbie BiggersDepartment of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, Amarillo, USA.
Serob T KaramyanDepartment of Pharmacology, Faculty of Pharmacy, Yerevan State Medical University, Yerevan, Armenia.
Thiruma V ArumugamDepartment of Physiology, Anatomy and Microbiology, School of Life Sciences, La Trobe University, Melbourne, Australia.
Fakhrul AhsanDepartment of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, Amarillo, USA.
Constantinos M MikelisDepartment of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, Amarillo, USA.
Taslim A Al-HilalDepartment of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, Amarillo, USA.
Vardan T KaramyanDepartment of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, Amarillo, USA; Center for Blood Brain Barrier Research, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, USA. Electronic address: vardan.karamyan@ttuhsc.edu.
Texas Tech University · USTexas Tech University Health Sciences Center · USLa Trobe University · AUYerevan State Medical University · AM

Funding

Development and Characterization of Small Molecule Activators of Peptidase Neurolysin for Stroke TherapyR01NS106879 · NINDS · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI Thomas J Abbruscato, Vardan T. Karamyan · 2018 to 2026
$4.2M
NINDS NIH HHS R01 NS106879
6 · The paper itself

Abstract

Treatments promoting post-stroke functional recovery continue to be an unmet therapeutic problem with physical rehabilitation being the most reproduced intervention in preclinical and clinical studies. Unfortunately, physiotherapy is typically effective at high intensity and early after stroke - requirements that are hardly attainable by stroke survivors. The aim of this study was to directly evaluate and compare the dose-dependent effect of delayed physical rehabilitation (daily 5 h or overnight voluntary wheel running; initiated on post-stroke day 7 and continuing through day 21) on recovery of motor function in the mouse photothrombotic model of ischemic stroke and correlate it with angiogenic potential of the brain. Our observations indicate that overnight but not 5 h access to running wheels facilitates recovery of motor function in mice in grid-walking test. Western blotting and immunofluorescence microscopy experiments evaluating the expression of angiogenesis-associated proteins VEGFR2, doppel and PDGFRβ in the peri-infarct and corresponding contralateral motor cortices indicate substantial upregulation of these proteins (≥2-fold) in the infarct core and surrounding cerebral cortex in the overnight running mice on post-stroke day 21. These findings indicate that there is a dose-dependent relationship between the extent of voluntary exercise, motor recovery and expression of angiogenesis-associated proteins in this expert-recommended mouse ischemic stroke model. Notably, our observations also point out to enhanced angiogenesis and presence of pericytes within the infarct core region during the chronic phase of stroke, suggesting a potential contribution of this tissue area in the mechanisms governing post-stroke functional recovery.

Indexed as

Angiogenic ProteinsPhysical Conditioning, AnimalStrokeAnimalsDisease Models, AnimalMiceMotor ActivityRecovery of FunctionUp-RegulationAngiogenic Proteinsangiogenesisinfarct coreneural repairpericytephysical rehabilitationpost-stroke recovery

Identifiers

PMID33667592
PMCPMC8044041
OpenAlexW3133809410

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.